Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure

C. Keller, R. Nanda, R. L. Shannon, Amnon Amit, Alan L. Kaplan

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Diethylstilbestrol (DES) was used widely in the late 1940s in an attempt to prevent adverse pregnancy outcomes. In 1971 the US Food and Drug Administration proscribed its use for pregnancy support secondary to its association with clear cell adenocarcinoma of the vagina. Several studies in animal models demonstrated an association with endometrial Cancer among offspring following in utero DES exposure. To date, there is only one case report of endometrial cancer in women exposed to DES in utero. We present the first case, to our knowledge, of a woman exposed to DES in utero who presented with double primaries of clear cell cancer of the vagina concomitant with endometrial cancer.

Original languageEnglish (US)
Pages (from-to)247-250
Number of pages4
JournalInternational Journal of Gynecological Cancer
Volume11
Issue number3
DOIs
StatePublished - Jul 19 2001

Keywords

  • Clear cell cancer of the vagina
  • Diethylstilbestrol
  • Endometrial neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure'. Together they form a unique fingerprint.

Cite this